Panacela Labs

Biotechnology, Health Care, Medical
Founded in 2011-01-01
New York, New York, United States
http://panacelalabs.com
For Profit

About Panacela Labs

Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation. Panacela Labs is 54.6% owned by Cleveland BioLabs. Panacela Labs has residency in the Innovation Center "Skolkovo".

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 8 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 39902600 USD
  • Last Funding: 2902600 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Panacela Labs actively uses 8 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical

Headquarters: New York, New York, United States